Home ›
Trademark Categories ›
Pharmaceuticals ›
2011 ›
ME ›
MELTEMI BIOTHERAPEUTICS
Trademark search for:
MELTEMI BIOTHERAPEUTICS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2011-10-18 — Application filed
2011-10-21 — Application filed
2011-10-21 — Application filed
2011-10-22 — Notice of design search code mailed
2012-02-06 — Assigned to examiner
2012-02-13 — Examiners amendment -written
2012-02-13 — Approved for pub - principal register
2012-02-13 — Examiner's amendment entered
2012-02-14 — Examiner's amendment mailed
2012-03-01 — Assigned to lie
2012-03-01 — Law office publication review completed
2012-03-14 — Notice of publication
2012-04-03 — Published for opposition
2012-05-29 — Noa mailed - sou required from applicant
2012-11-29 — Sou teas extension received
2012-11-29 — Sou extension 1 filed
2012-11-29 — Sou extension 1 granted
2012-12-01 — Notice of approval of extension request mailed
2013-04-18 — Sou teas extension received
2013-04-18 — Sou extension 2 filed
2013-05-10 — Case assigned to intent to use paralegal
2013-05-16 — Sou extension 2 granted
2013-05-17 — Notice of approval of extension request mailed
2013-09-10 — Sou teas extension received
2013-09-10 — Sou extension 3 filed
2013-09-23 — Sou extension 3 granted
2013-09-24 — Notice of approval of extension request mailed
2014-03-13 — Sou teas extension received
2014-03-13 — Sou extension 4 filed
2014-04-01 — Sou extension 4 granted
2014-04-02 — Notice of approval of extension request mailed
2014-10-17 — Sou teas extension received
2014-10-17 — Sou extension 5 filed
2014-10-21 — Sou extension 5 granted
2014-10-22 — Notice of approval of extension request mailed
2015-04-07 — Assigned to examiner
2015-06-29 — Application abandoned
2015-06-29 — Application abandoned
2015-06-29 — Final status recorded
Owner Information
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Correspondent
ANN LAMPORT HAMMITTE LANDO & ANASTASI, LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
